FDA NDC Directory · JSON-LD · Markdown
NDC 72657-124 · HUMAN OTC DRUG · CAPSULE, DELAYED RELEASE
| Labeler / Manufacturer | GLENMARK THERAPEUTICS INC., USA |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA216349 |
| Dosage form / route | CAPSULE, DELAYED RELEASE · ORAL |
| Active ingredients | ESOMEPRAZOLE MAGNESIUM (20 mg/1) |
| Marketing started | 20230822 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).